New Drug Approvals Archive - April 2004
Get news by email or subscribe to our news feeds.
April 2004
| April 5 |
Cardizem LA (diltiazem hydrochloride)
New Indication Approved: April 2, 2004
|
| April 7 |
Nasacort (triamcinolone acetonide)
New Formulation Approved: April 7, 2004
|
| April 6 |
Ribasphere (ribavirin) Capsules Date of Approval: April 6, 2004
Company: Three Rivers Pharmaceuticals, LLC
Treatment for: Chronic Hepatitis C
Ribasphere (ribavirin) is a nucleoside analogue indicated in combination with peginterferon alfa-2a for the
treatment of adults with chronic hepatitis C virus infection. Ribasphere (ribavirin) FDA Approval History |
| April 9 |
ChiRhoStim (secretin synthetic human) - formerly Human SecretinDate of Approval: April 9, 2004
Company: ChiRhoClin, Inc.
Treatment for: Diagnostic
ChiRhoStim is indicated for use in diagnostic procedures. ChiRhoStim (secretin synthetic human) FDA Approval History |
| April 16 |
Apidra (insulin glulisine) Injection Date of Approval: April 16, 2004
Company: Aventis Pharmaceuticals Inc.
Treatment for: Diabetes Type 1, Diabetes Type 2
Apidra (insulin glulisine) is a rapid-acting recombinant DNA human insulin analogue used for the control of hyperglycemia in patients with diabetes mellitus. Apidra (insulin glulisine) FDA Approval History |
| April 20 |
Apokyn (apomorphine) Injection Date of Approval: April 20, 2004
Company: Bertek Pharmaceuticals
Treatment for: Parkinson's Disease
Apokyn (apomorphine) is a non-ergoline dopamine agonist indicated for the acute, intermittent treatment of hypomobility, "off" episodes ("end-of-dose wearing
off" and unpredictable "on/off" episodes) associated with advanced
Parkinson’s disease. Apokyn (apomorphine) FDA Approval History |
| April 28 |
Fortamet (metformin) Extended-Release Tablets Date of Approval: April 28, 2004
Company: Andrx Corporation
Treatment for: Diabetes Type 2
Fortamet (metformin) is an extended-release antihyperglycemic for the treatment of type
2 diabetes. Fortamet (metformin) FDA Approval History |
| June 15 |
Apidra (insulin glulisine)
New Dosage Regimen: April 12, 2007
Apidra (insulin glulisine) FDA Approval History |
| October 29 |
Apidra (insulin glulisine)
Patient Population Altered: October 24, 2008
Apidra (insulin glulisine) FDA Approval History |
| February 26 |
Apidra (insulin glulisine)
New Dosage Form Approved: February 24, 2009
Apidra (insulin glulisine) FDA Approval History |
New Drug Approvals Archive
2016
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2015
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2014
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2013
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2012
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2011
January,
February,
March,
April,
May,
June,
July,
August,
October,
November,
December2010
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2009
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2008
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2007
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2006
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2005
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2004
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December2003
January,
February,
March,
April,
May,
June,
July,
August,
September,
October,
November,
December
